Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer
- Conditions
- Breast CancerSurgery
- Interventions
- Other: Coaching sessions
- Registration Number
- NCT04469205
- Lead Sponsor
- Institut Curie
- Brief Summary
Evaluate the impact of coaching sessions on the return to work rate (number of patients returning at work / total number of patients per arm) 6 months after inclusion in the study for breast cancer in professionnally active patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 69
Any patient active at the time of the diagnosis of breast cancer, treated consecutively at the Institut Curie during the study period, and whose first treatment will be surgery, will be offered participation in the study.
- Invasive non-metastatic breast cancer, treated first by surgery
- Age ≥ 18 and ≤ 60 years
- Active woman at the time of diagnosis
- Patient with internet access and email address
- Patient affiliated with a social security scheme, speaking and reading French
- Signature of informed consent
- In situ breast cancer
- History of breast cancer
- Metastatic breast cancer
- Inflammatory Breast Cancer
- Woman with a life expectancy <6 months at the time of diagnosis (in relation to other serious chronic diseases)
- Persons deprived of liberty or under guardianship
- Impossibility to submit to the medical follow-up of the test for geographical, social or psychological reasons
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Group Coaching sessions intervention group that will receive return-to-work coaching sessions. The intervention consists of 3 individual coaching sessions with a certified professional coach. This personalized accompaniment will complete the standard accompaniment offered to all patients.
- Primary Outcome Measures
Name Time Method Impact of coaching sessions on the return to work rate (number of patients returning at work / total number of patients per arm) 6 months after inclusion in the study 6 months The rate of patients returning to work (part-time or full-time) for more than 2 weeks to 6 months of inclusion in the study in each group.
- Secondary Outcome Measures
Name Time Method Sustainability of the return to work 6 and 12 months Evaluation of the durability of the return to work at 6 and 12 months after inclusion by registration by the patients of the number of days off work and / or working time arrangement
The determinants of return to work (factors associated with a return to work "successful": early, sustainable and quality) 6 and 12 months These determinants will also be evaluated through the collection of socio-demographic data, cancer characteristics and treatments administered.
Quality of the return to work 6 and 12 months Evaluation of the quality of the return to work at 6 and 12 months after inclusion by questionnaire VOW / QFT (in case of return to work only).
Evaluation scale : 1=never to 4=everImpact of the return to work / work stoppage on the quality of life 6 and 12 months Evaluation of the impact of return to work / work stoppage on the quality of life estimated by QLQ-C30 questionnaire at baseline and at 6 and 12 months post-inclusion
The production losses related to presenteeism during maintenance or return to work 6 and 12 months Evaluation of the loss of productivity during a professional activity : in case of return to work, the "Work limitation questionnaire" will be completed at 6 and 12 months after inclusion
The medico-economic impact of returning to work 12 months Evaluation of the medico-economic impact of return to work by comparing the costs of care in the two groups
Trial Locations
- Locations (1)
Institut Curie
🇫🇷Saint-Cloud, France